Navigation Links
12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system)

SAN DIEGO, May 23, 2007 /PRNewswire-FirstCall/ -- Shire plc announced that DAYTRANA(TM) (methylphenidate transdermal system), the first and only non-oral medication approved for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12 years, provided significant improvement in symptom control and tolerability, according to results of a 12-month open-label study presented at the American Psychiatric Association (APA) annual meeting in San Diego.

"We documented that children with ADHD experienced effective ADHD treatment with use of DAYTRANA for 12 months, sustaining the improvements in their ability to maintain focus and concentration," said investigator Oscar Bukstein, M.D., Associate Professor of Psychiatry, University of Pittsburgh School of Medicine. "More importantly, Daytrana maintained a favorable safety profile, meeting the study's primary endpoint, and demonstrating an incidence of adverse events that is consistent with previous trials and other stimulants in this class."

Shire's DAYTRANA is the first and only patch medication approved by the U.S. Food and Drug Administration (FDA) to treat the symptoms of ADHD in children aged 6 to 12 years. DAYTRANA is available in four dosage strengths - 10 mg, 15 mg, 20 mg and 30 mg - all designed for once-daily use. When worn for the recommended nine hours, efficacy has been demonstrated from the first time point measured (two hours) through the 12-hour time point. Because DAYTRANA is a patch, physicians may recommend that patients shorten the wear time if shorter duration of effect is desired or to help manage the potential for late-day side effects.

Bukstein added, "DAYTRANA's novel patch delivery system offers physicians and parents of children with ADHD a convenient, non-oral option to individualize ADHD treatment to meet their children's changing schedules."

This study was an open-label extension of four
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

Post Your Comments:
(Date:11/24/2009)...tCall/--BioSpecificsTechnologiesCorp.(Nasdaq: BSTC...collagenase-basedproducts,todayannouncedthatBioSpe...gPiperJaffray21stAnnualHealthCareConferenceonTuesd...linNewYork,NY. ,, Alivewebcastofthepresentation...elationssectionoftheCompany,swebsiteat www.biospec...
(Date:11/23/2009)...Chicagoarea,sleadingBoardCertifiedDiagnosticRadiol...couplingthelatesttechnologyindigitalmammography,bo...vethefullrangeofdigitalimagingcompleted,diagnoseda...Drs.AhmedFaragandJoanWerberaredeliveringthispatien...ranappointmentcommonlyfoundinChicago,fromtheirnewo...
(Date:11/23/2009)...Call/--BostonScientificCorporation(NYSE: BSX )issc...ference,December1-2. ,, RayElliott,Presidentand...dentandChiefFinancialOfficer,willparticipateina30-...st,beginningatapproximately9:00a.m.E.T. ,, Aliv...stedpartiesatBostonScientific,swebsiteat www.bosto...
Breaking Medicine Technology:University of Basque Country research study on effects of climate on plankton in the estuaries 10148 1University of Basque Country research study on effects of climate on plankton in the estuaries 10148 2Type 2 Diabetes Drug May Increase Fracture Risk 58451 1Social Status as a Teen Predicts Health as an Adult 58449 1Social Status as a Teen Predicts Health as an Adult 58449 2Social Status as a Teen Predicts Health as an Adult 58449 3
...acebo Larger at One Year than at Six,Months -, SAN...re-FirstCall/ -- Medivation, Inc. today announced ...ouble-blind,placebo-controlled Phase 2 study in m...cally significant on all five study endpoints,at 1...the benefits,of Dimebon over placebo at one year w...
... 2007 /PRNewswire/ -- NovaCardia, Inc.,today prese...l of,KW-3902, an adenosine A1 receptor antagonist ...acute congestive heart failure (CHF),that indicat...ram,dose. Patients treated with KW-3902 experience...tness of breath, which is a common,symptom of CHF,...
Other Medicine Technology:Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 2Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 3Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 4Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 5Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 6Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 2Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 3Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive,Heart Failure Presented at Late-Breaking Session of Heart Failure,Congress 2007 4
(Date:11/24/2009)...release is available in German . , Internat...en with cancer is very good as far as survival is ... of life, pain, and long-term consequences of the ...tudies. This is the conclusion of the Institute fo... its final report published on 16 October 2009. ,...
(Date:11/24/2009)...y-associated strains have increased sevenfold, stu...ay News) -- Strains of antibiotic-resistant infect...gly showing up among hospital outpatients, raising...ew research says. , From 1999 to 2006, research... outpatients with methicillin-resistant Staphyloc...
(Date:11/24/2009)... This November, Home Care Deliver...tional movement to raise awareness for a disease t... Richmond, VA (Vocus) November 24, 2009 ...iation (ADA), Home Care Delivered recognizes Nat...during the month of November. Nearly 24 million Am...
(Date:11/24/2009)...SANDIEGO,Nov.24/PRNewswire-FirstCall/--USFarms,Inc...urseryandWellnessproductsispleasedtoannounceithasr...etarianAssociation(AVA)foritsAloe365(TM)Juiceprodu...verypleasedtoannouncethatwehavecompletedthecertifi...ithour32oz.Aloe365(TM)Juice.TheprimarygoaloftheAVA...
(Date:11/24/2009)...MORRISVILLE,N.C.,Nov.24/PRNewswire/--TheAmericanSo...esultsofasurveyabouttheimpactofthe2010CMSPhysician...ardiologistsandcardiovascularultrasoundtechnicians...hemtostopacceptingMedicarepatients,reducestafforsh...atientaccesstoechocardiography(heartultrasound)and...
Breaking Medicine News(10 mins):Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3Health News:MRSA Creeping Into Hospitals From the Outside 2Health News:MRSA Creeping Into Hospitals From the Outside 3Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product 2Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2
...new study has found that children with both autism...ur times more likely to bully than children in th... are cautioning against labelling kids with autism... to be properly channeled, or they may have other ...
... order to makeup for the loss of the four sick pub...the hospitals run by state governments , the railw...se drugs from them to make them profit making unit...tan Insecticides Limited and Hindustan Organic Che...
...llywood star Sylvester Stallone has apologized pro... and testosterone into Australia. Stallone h...nto Australia in February this year during a tour ...ed human growth hormone product, Jintropin. ...
...ousands of people made a beeline for guru Ramdev's... A ground has been specially prepared on the ou...e week-long course that ends May 22. Organ...ment has made special arrangements to run buses to...
... researchers have discovered a non-invasive elasto...uscular disease without exposing patients to radi...ased Scripps Institute of Oceanography researchers...metres apart, along the thigh of a healthy male vo...
...een campaigners in India are worried, as the flood...o shopping malls, residential and commercial outl...s. This will further choke the highly poll...t in New Delhi. It is being organized by Jal Birad...
Other Medicine News:Health News:Kids With Both Autism and ADHD Four Times More Likely to Bully 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2Health News:Sylvester Stallone Regrets Smuggling Banned Substances to Australia 2Health News:Sylvester Stallone Regrets Smuggling Banned Substances to Australia 3Health News:Green Campaigners Concerned About Yamuna's Shrinking Floodplains 2
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: